Repatha 140 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DB25FC63S
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,222
Award facts
- Contract value 100% obligated
- $18,221.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,221.94 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract, issued on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a firm fixed-price procurement with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the distribution of medications and medical supplies to military healthcare programs worldwide.
As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare systems. Repatha is a PCSK9 inhibitor used to treat high cholesterol and cardiovascular disease, reflecting the company's role in supplying specialty medications across multiple therapeutic domains. The non-set-aside, competitive award demonstrates AmerisourceBergen's established capability to meet federal procurement requirements and aligns with the Defense Logistics Agency's strategic pharmaceutical supply chain operations supporting military medical readiness and healthcare delivery.
Quick answers
Who was awarded contract SPE2DB25FC63S?
SPE2DB25FC63S was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 4, 2025.
How much is contract SPE2DB25FC63S worth?
The government has obligated $18,222 on SPE2DB25FC63S.
Is contract SPE2DB25FC63S an order under another contract?
Yes. SPE2DB25FC63S is a delivery order under SPE2DB20D2014, an indefinite delivery contract.
Was contract SPE2DB25FC63S competed?
The extent of competition for SPE2DB25FC63S was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award